Dr. Oregonin Completes U.S. FDA Registration for OLTIS DENTAL-X Oral-Care Product
Dr. Oregonin Inc. has completed U.S. Food and Drug Administration (FDA) registration for its OLTIS DENTAL-X oral-care product. The product utilizes research on the alder compound 'oregonin'.
Dr. Oregonin Inc. has completed its registration with the U.S. Food and Drug Administration (FDA) for the OLTIS DENTAL-X oral-care product. The product leverages the discovery of the compound 'oregonin' at Oregon State University in 1974.
The development combines this original finding with 27 years of natural product research conducted by South Korean scientists. Dr. Oregonin Inc. aims to introduce a new line of oral-care products based on natural ingredients.
The FDA registration permits the product's sale within the United States market. The company has not yet provided specific details regarding the product's availability or pricing in the U.S. This registration marks a key step for the company's expansion efforts.